Question 1

What is combined oxidative phosphorylation defect type 24?

Accepted Answer

Combined oxidative phosphorylation defect type 24 is a condition affecting energy production in cells due to abnormalities in mitochondrial function. It is caused by mutations in the NARS2 gene, which plays a key role in protein synthesis within mitochondria. This condition is inherited in an autosomal recessive pattern and is very rare, affecting fewer than 1 in 1,000,000 people. Individuals with the disorder may present symptoms in early childhood, although the severity and range of manifestations can vary substantially.

Question 2

What are the symptoms of combined oxidative phosphorylation defect type 24?

Accepted Answer

Characteristic findings in this condition include the consistent presence of ragged-red muscle fibers and decreased activity of both mitochondrial complex IV and complex I, findings that are considered obligate features. Patients may also experience skeletal muscle atrophy, easy fatigability, dysarthria, seizures, ptosis, elevated circulating creatine kinase, proximal muscle weakness, and mild intellectual disability, along with weakness of facial musculature. Not all individuals experience all of these features, and the severity varies considerably. Although some cognitive challenges are noted, there is no distinct phase of developmental regression reported.

Question 3

What causes combined oxidative phosphorylation defect type 24?

Accepted Answer

This condition is caused by mutations in the NARS2 gene, which is essential for proper mitochondrial protein synthesis and energy production. It is inherited in an autosomal recessive manner, meaning that an affected individual has received one mutated copy of the gene from each parent. Because the disorder is very rare, it is more common when parents share a common ancestor, increasing the likelihood that both carry the same rare mutation. Families are advised to pursue genetic counseling to understand the recurrence risk and implications for future family planning. Associated genes include NARS2.

Question 4

How is combined oxidative phosphorylation defect type 24 inherited?

Accepted Answer

combined oxidative phosphorylation defect type 24 follows an autosomal recessive inheritance pattern. This means a child must inherit a copy of the altered gene from both parents to develop the condition. Parents who each carry one copy typically do not show symptoms.

Question 5

How rare is combined oxidative phosphorylation defect type 24?

Accepted Answer

combined oxidative phosphorylation defect type 24 is classified as very rare. The estimated prevalence is approximately <1 in 1,000,000. Because rare disease data can be limited, actual numbers may differ from published estimates.

Question 6

How is combined oxidative phosphorylation defect type 24 diagnosed?

Accepted Answer

Molecular genetic testing is the gold standard for diagnosing combined oxidative phosphorylation defect type 24, with confirmation achieved by identifying pathogenic variants in the NARS2 gene. Clinical evaluation, which takes into account characteristic findings such as ragged-red muscle fibers and decreased activity of mitochondrial complexes, supports the diagnosis. Because similar symptoms can occur in other conditions, genetic testing is essential to definitively distinguish this disorder from others with overlapping clinical presentations.

Question 7

Are there treatments for combined oxidative phosphorylation defect type 24?

Accepted Answer

Currently, management focuses on supportive care and symptom management since there are no established foundational therapies or FDA-approved treatments for this condition. A multidisciplinary team approach, involving specialists experienced in mitochondrial disorders, is recommended to address the range of symptoms including neuromuscular and cognitive challenges. Regular surveillance is an essential part of long-term care, as ongoing monitoring can help identify and manage potential complications early. Patients should discuss treatment options with their healthcare team and consider genetic counseling to guide family planning and overall management.

Question 8

What are the potential complications of combined oxidative phosphorylation defect type 24?

Accepted Answer

Complications of combined oxidative phosphorylation defect type 24 can vary widely among individuals. Some patients may experience severe muscle weakness, which can lead to mobility challenges, while others might face cognitive difficulties. Regular monitoring by a healthcare team is important to identify and manage any complications early on.

Question 9

How does combined oxidative phosphorylation defect type 24 affect daily life and activities?

Accepted Answer

Daily life for individuals with combined oxidative phosphorylation defect type 24 can be impacted by symptoms like muscle weakness and easy fatigability. This may limit physical activities and require adjustments in daily routines. Supportive care and a tailored approach from healthcare providers can help improve quality of life.

Question 10

What is the life expectancy for someone with combined oxidative phosphorylation defect type 24?

Accepted Answer

The life expectancy for individuals with combined oxidative phosphorylation defect type 24 is not clearly defined, as it can vary based on symptom severity and access to specialized care. Many individuals can lead fulfilling lives with appropriate management and support. Ongoing care and monitoring are essential for optimizing health outcomes.

Question 11

What specialists should be involved in the care of someone with combined oxidative phosphorylation defect type 24?

Accepted Answer

A multidisciplinary team is recommended for managing combined oxidative phosphorylation defect type 24. This team may include specialists in mitochondrial disorders, neurology, and genetics. Working with these experts can help address the range of symptoms and provide comprehensive care tailored to the individual's needs.

Kisho

combined oxidative phosphorylation defect type 24

Overview

Clinical Presentation

Genetic Landscape

Diagnosis

Prognosis

Research Landscape

Recent Publications

Medical References

External Resources

OMIM

Orphanet

GARD

Questions for Your Care Team

Questions for Your Care Team

FAQ

Frequently Asked Questions

Explore clinical features

combined oxidative phosphorylation defect type 24

Overview

Clinical Presentation

Genetic Landscape

Diagnosis

Prognosis

Research Landscape

Recent Publications

Medical References

External Resources

OMIM

Orphanet

GARD

Related Diseases

Questions for Your Care Team

Questions for Your Care Team

FAQ

Frequently Asked Questions

What is combined oxidative phosphorylation defect type 24?

What are the symptoms of combined oxidative phosphorylation defect type 24?

What causes combined oxidative phosphorylation defect type 24?

How is combined oxidative phosphorylation defect type 24 inherited?

How rare is combined oxidative phosphorylation defect type 24?

How is combined oxidative phosphorylation defect type 24 diagnosed?

Are there treatments for combined oxidative phosphorylation defect type 24?

What are the potential complications of combined oxidative phosphorylation defect type 24?

How does combined oxidative phosphorylation defect type 24 affect daily life and activities?

What is the life expectancy for someone with combined oxidative phosphorylation defect type 24?

What specialists should be involved in the care of someone with combined oxidative phosphorylation defect type 24?

Explore clinical features